2162 GENES FOUNDi
Show / hide columns Aggregate: Custom reports Download: XML | RDF | TSV | JSON | Custom TSV/JSON Page of 44 | next ยป
Genei
Gene descriptioni x
Evidencei x
Tissuei
Braini
Single celli
Subcelli
Canceri
Bloodi
Cell linei
Struct & Inti
Prognostic p-valuei x
DKK1Dickkopf WNT signaling pathway inhibitor 1
Lung Adenocarcinoma (TCGA): 4.83e-10
Head and Neck Squamous Cell Carcinoma (TCGA): 1.32e-8
Pancreatic Adenocarcinoma (TCGA): 1.09e-4
Pancreatic Adenocarcinoma (validation): 1.21e-4
Lung Adenocarcinoma (validation): 3.46e-4
EIF5AEukaryotic translation initiation factor 5A
Lung Adenocarcinoma (TCGA): 8.62e-9
Kidney Renal Clear Cell Carcinoma (validation): 3.45e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.81e-6
Bladder Urothelial Carcinoma (TCGA): 1.46e-4
ANLNAnillin, actin binding protein
Liver Hepatocellular Carcinoma (validation): 2.40e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.71e-9
Lung Adenocarcinoma (TCGA): 9.34e-8
Pancreatic Adenocarcinoma (TCGA): 1.84e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.73e-6
Liver Hepatocellular Carcinoma (TCGA): 9.35e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.27e-4
Lung Adenocarcinoma (validation): 1.34e-4
Kidney Chromophobe (TCGA): 6.88e-4
MCM5Minichromosome maintenance complex component 5
Liver Hepatocellular Carcinoma (validation): 9.08e-8
Lung Adenocarcinoma (TCGA): 1.29e-7
Liver Hepatocellular Carcinoma (TCGA): 4.86e-5
PLIN3Perilipin 3
Lung Adenocarcinoma (TCGA): 1.42e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 9.98e-6
Kidney Renal Clear Cell Carcinoma (validation): 2.66e-5
Liver Hepatocellular Carcinoma (TCGA): 1.83e-4
Lung Adenocarcinoma (validation): 5.74e-4
Liver Hepatocellular Carcinoma (validation): 7.66e-4
Uterine Corpus Endometrial Carcinoma (TCGA): 8.98e-4
KNSTRNKinetochore localized astrin (SPAG5) binding protein
Lung Adenocarcinoma (TCGA): 1.42e-7
Pancreatic Adenocarcinoma (TCGA): 1.83e-6
Liver Hepatocellular Carcinoma (TCGA): 5.39e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.49e-4
Kidney Chromophobe (TCGA): 1.98e-4
Lung Adenocarcinoma (validation): 5.97e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.83e-4
SEC61GSEC61 translocon subunit gamma
Liver Hepatocellular Carcinoma (TCGA): 2.45e-8
Lung Adenocarcinoma (TCGA): 1.81e-7
Head and Neck Squamous Cell Carcinoma (TCGA): 6.26e-7
Liver Hepatocellular Carcinoma (validation): 2.64e-6
Breast Invasive Carcinoma (TCGA): 1.55e-5
Kidney Chromophobe (TCGA): 1.89e-4
ECT2Epithelial cell transforming 2
Lung Adenocarcinoma (TCGA): 2.34e-7
Kidney Renal Clear Cell Carcinoma (validation): 7.43e-7
Liver Hepatocellular Carcinoma (TCGA): 1.04e-6
Liver Hepatocellular Carcinoma (validation): 2.71e-6
Pancreatic Adenocarcinoma (TCGA): 2.41e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 8.89e-4
PKMYT1Protein kinase, membrane associated tyrosine/threonine 1
Kidney Renal Clear Cell Carcinoma (TCGA): 1.97e-8
Lung Adenocarcinoma (TCGA): 3.43e-7
Liver Hepatocellular Carcinoma (validation): 5.45e-7
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.25e-5
Kidney Renal Clear Cell Carcinoma (validation): 5.09e-5
Liver Hepatocellular Carcinoma (TCGA): 2.16e-4
Kidney Chromophobe (TCGA): 2.63e-4
GAPDHGlyceraldehyde-3-phosphate dehydrogenase
Liver Hepatocellular Carcinoma (validation): 2.08e-10
Lung Adenocarcinoma (TCGA): 4.40e-7
Liver Hepatocellular Carcinoma (TCGA): 2.44e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.98e-5
Lung Adenocarcinoma (validation): 8.92e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 4.62e-4
DEPDC1BDEP domain containing 1B
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.03e-8
Lung Adenocarcinoma (TCGA): 4.53e-7
Liver Hepatocellular Carcinoma (validation): 5.68e-6
Lung Adenocarcinoma (validation): 4.16e-5
Liver Hepatocellular Carcinoma (TCGA): 1.37e-4
Kidney Renal Clear Cell Carcinoma (validation): 1.83e-4
CCNB1Cyclin B1
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.11e-10
Liver Hepatocellular Carcinoma (validation): 3.97e-10
Liver Hepatocellular Carcinoma (TCGA): 3.16e-9
Lung Adenocarcinoma (TCGA): 4.69e-7
Kidney Renal Clear Cell Carcinoma (validation): 2.43e-5
Lung Adenocarcinoma (validation): 4.74e-4
Kidney Chromophobe (TCGA): 5.21e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.61e-4
GALNT2Polypeptide N-acetylgalactosaminyltransferase 2
Lung Adenocarcinoma (TCGA): 6.02e-7
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 4.55e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 4.88e-5
Rectum Adenocarcinoma (TCGA): 7.37e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 4.10e-4
Lung Adenocarcinoma (validation): 8.18e-4
Kidney Renal Clear Cell Carcinoma (validation): 9.27e-4
LOXL2Lysyl oxidase like 2
Lung Adenocarcinoma (TCGA): 6.51e-7
Lung Adenocarcinoma (validation): 1.17e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.58e-4
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 3.31e-4
Ovary Serous Cystadenocarcinoma (validation): 6.84e-4
FKBP4FKBP prolyl isomerase 4
Lung Adenocarcinoma (TCGA): 6.92e-7
Liver Hepatocellular Carcinoma (validation): 5.31e-6
Liver Hepatocellular Carcinoma (TCGA): 1.45e-5
Colon Adenocarcinoma (validation): 3.72e-4
ALDOAAldolase, fructose-bisphosphate A
Liver Hepatocellular Carcinoma (TCGA): 3.58e-7
Lung Adenocarcinoma (TCGA): 7.02e-7
Liver Hepatocellular Carcinoma (validation): 2.90e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.25e-4
Bladder Urothelial Carcinoma (TCGA): 5.34e-4
Lung Adenocarcinoma (validation): 7.09e-4
HMMRHyaluronan mediated motility receptor
Liver Hepatocellular Carcinoma (validation): 2.42e-9
Liver Hepatocellular Carcinoma (TCGA): 2.87e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.93e-7
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.18e-7
Lung Adenocarcinoma (TCGA): 7.17e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 5.33e-5
Lung Adenocarcinoma (validation): 3.79e-4
Pancreatic Adenocarcinoma (TCGA): 5.47e-4
Kidney Chromophobe (TCGA): 5.83e-4
PGAM1Phosphoglycerate mutase 1
Lung Adenocarcinoma (TCGA): 8.61e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 3.37e-5
Lung Adenocarcinoma (validation): 7.00e-5
Breast Invasive Carcinoma (TCGA): 4.53e-4
SPDL1Spindle apparatus coiled-coil protein 1
Lung Adenocarcinoma (TCGA): 1.14e-6
Pancreatic Adenocarcinoma (TCGA): 1.45e-6
Liver Hepatocellular Carcinoma (TCGA): 1.17e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.68e-5
Pancreatic Adenocarcinoma (validation): 5.46e-4
ITGA6Integrin subunit alpha 6
Kidney Renal Clear Cell Carcinoma (TCGA): 1.37e-14
Lung Adenocarcinoma (TCGA): 1.15e-6
Kidney Renal Clear Cell Carcinoma (validation): 8.09e-4
Glioblastoma Multiforme (validation): 8.82e-4
KIF23Kinesin family member 23
Kidney Renal Clear Cell Carcinoma (TCGA): 4.28e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.42e-7
Liver Hepatocellular Carcinoma (validation): 2.97e-7
Kidney Renal Clear Cell Carcinoma (validation): 3.55e-7
Lung Adenocarcinoma (TCGA): 1.19e-6
Liver Hepatocellular Carcinoma (TCGA): 4.63e-6
Pancreatic Adenocarcinoma (TCGA): 1.67e-5
Kidney Chromophobe (TCGA): 1.64e-4
Lung Adenocarcinoma (validation): 1.82e-4
GBE11,4-alpha-glucan branching enzyme 1
Lung Adenocarcinoma (TCGA): 1.38e-6
Kidney Chromophobe (TCGA): 2.06e-4
Lung Adenocarcinoma (validation): 4.49e-4
Liver Hepatocellular Carcinoma (TCGA): 9.81e-4
CCT6AChaperonin containing TCP1 subunit 6A
Liver Hepatocellular Carcinoma (validation): 7.38e-9
Kidney Renal Clear Cell Carcinoma (TCGA): 4.16e-7
Lung Adenocarcinoma (TCGA): 1.45e-6
Liver Hepatocellular Carcinoma (TCGA): 2.19e-5
Bladder Urothelial Carcinoma (TCGA): 1.01e-4
PPIAPeptidylprolyl isomerase A
Liver Hepatocellular Carcinoma (validation): 4.58e-10
Lung Adenocarcinoma (TCGA): 1.78e-6
Liver Hepatocellular Carcinoma (TCGA): 2.13e-5
Kidney Renal Clear Cell Carcinoma (validation): 3.93e-4
Pancreatic Adenocarcinoma (TCGA): 4.07e-4
Head and Neck Squamous Cell Carcinoma (TCGA): 4.50e-4
TYMSThymidylate synthetase
Liver Hepatocellular Carcinoma (validation): 1.00e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 1.58e-6
Lung Adenocarcinoma (TCGA): 1.80e-6
Pancreatic Adenocarcinoma (TCGA): 1.81e-6
Liver Hepatocellular Carcinoma (TCGA): 6.02e-5
UCK2Uridine-cytidine kinase 2
Liver Hepatocellular Carcinoma (TCGA): 1.98e-11
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.65e-7
Liver Hepatocellular Carcinoma (validation): 7.28e-7
Lung Adenocarcinoma (TCGA): 2.44e-6
Skin Cuteneous Melanoma (TCGA): 7.33e-5
Bladder Urothelial Carcinoma (TCGA): 2.67e-4
Pancreatic Adenocarcinoma (TCGA): 6.69e-4
RACGAP1Rac GTPase activating protein 1
Liver Hepatocellular Carcinoma (validation): 1.86e-7
Lung Adenocarcinoma (TCGA): 2.70e-6
Liver Hepatocellular Carcinoma (TCGA): 3.21e-6
Lung Adenocarcinoma (validation): 3.44e-5
Kidney Renal Papillary Cell Carcinoma (TCGA): 3.51e-5
Kidney Chromophobe (TCGA): 1.10e-4
Pancreatic Adenocarcinoma (TCGA): 1.29e-4
Kidney Renal Clear Cell Carcinoma (validation): 5.95e-4
Breast Invasive Carcinoma (TCGA): 9.25e-4
CDCA3Cell division cycle associated 3
Liver Hepatocellular Carcinoma (validation): 6.05e-11
Kidney Renal Clear Cell Carcinoma (TCGA): 6.34e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.56e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.75e-7
Liver Hepatocellular Carcinoma (TCGA): 1.87e-6
Lung Adenocarcinoma (TCGA): 3.03e-6
Pancreatic Adenocarcinoma (TCGA): 2.34e-4
Kidney Chromophobe (TCGA): 9.15e-4
UBE2E3Ubiquitin conjugating enzyme E2 E3
Lung Adenocarcinoma (TCGA): 3.10e-6
Liver Hepatocellular Carcinoma (validation): 1.38e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 6.30e-5
Liver Hepatocellular Carcinoma (TCGA): 3.36e-4
Pancreatic Adenocarcinoma (TCGA): 3.91e-4
WDR4WD repeat domain 4
Lung Adenocarcinoma (TCGA): 3.10e-6
Liver Hepatocellular Carcinoma (TCGA): 4.84e-6
Liver Hepatocellular Carcinoma (validation): 7.77e-6
VDAC1Voltage dependent anion channel 1
Head and Neck Squamous Cell Carcinoma (TCGA): 6.25e-8
Lung Adenocarcinoma (TCGA): 3.10e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 4.10e-6
Breast Invasive Carcinoma (TCGA): 1.60e-5
Lung Adenocarcinoma (validation): 7.13e-4
CENPFCentromere protein F
Kidney Renal Papillary Cell Carcinoma (TCGA): 5.49e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.58e-7
Lung Adenocarcinoma (TCGA): 3.18e-6
Kidney Renal Clear Cell Carcinoma (TCGA): 3.33e-6
Liver Hepatocellular Carcinoma (validation): 6.56e-6
Kidney Chromophobe (TCGA): 1.17e-5
Liver Hepatocellular Carcinoma (TCGA): 2.64e-5
Pancreatic Adenocarcinoma (TCGA): 4.13e-4
BMAL2Basic helix-loop-helix ARNT like 2
Pancreatic Adenocarcinoma (TCGA): 4.82e-8
Lung Adenocarcinoma (TCGA): 3.26e-6
Pancreatic Adenocarcinoma (validation): 4.50e-4
Lung Adenocarcinoma (validation): 6.58e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.08e-4
COA6Cytochrome c oxidase assembly factor 6
Lung Adenocarcinoma (TCGA): 3.77e-6
Head and Neck Squamous Cell Carcinoma (TCGA): 1.24e-4
Kidney Renal Clear Cell Carcinoma (TCGA): 7.59e-4
Kidney Renal Clear Cell Carcinoma (validation): 7.71e-4
Kidney Renal Papillary Cell Carcinoma (TCGA): 8.29e-4
CDKN3Cyclin dependent kinase inhibitor 3
Liver Hepatocellular Carcinoma (validation): 5.00e-10
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.30e-8
Kidney Renal Clear Cell Carcinoma (validation): 2.38e-7
Kidney Renal Clear Cell Carcinoma (TCGA): 9.21e-7
Lung Adenocarcinoma (TCGA): 3.93e-6
Kidney Chromophobe (TCGA): 4.42e-6
Ovary Serous Cystadenocarcinoma (validation): 8.24e-5
Pancreatic Adenocarcinoma (TCGA): 6.57e-4
Liver Hepatocellular Carcinoma (TCGA): 7.07e-4
TUBA1BTubulin alpha 1b
Liver Hepatocellular Carcinoma (TCGA): 2.22e-10
Kidney Renal Clear Cell Carcinoma (TCGA): 1.54e-6
Lung Adenocarcinoma (TCGA): 4.09e-6
Kidney Renal Clear Cell Carcinoma (validation): 6.78e-6
Liver Hepatocellular Carcinoma (validation): 9.54e-6
Lung Adenocarcinoma (validation): 1.62e-5
Breast Invasive Carcinoma (TCGA): 8.62e-5
CCT8Chaperonin containing TCP1 subunit 8
Lung Adenocarcinoma (TCGA): 4.34e-6
Liver Hepatocellular Carcinoma (TCGA): 4.78e-6
Liver Hepatocellular Carcinoma (validation): 1.69e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 8.44e-5
Head and Neck Squamous Cell Carcinoma (TCGA): 1.24e-4
Lung Adenocarcinoma (validation): 2.79e-4
Breast Invasive Carcinoma (TCGA): 6.83e-4
DNASE1L3Deoxyribonuclease 1 like 3
Kidney Renal Clear Cell Carcinoma (TCGA): 1.23e-10
Liver Hepatocellular Carcinoma (TCGA): 4.72e-7
Lung Adenocarcinoma (TCGA): 4.38e-6
Liver Hepatocellular Carcinoma (validation): 1.85e-5
Kidney Renal Clear Cell Carcinoma (validation): 1.25e-4
KIF14Kinesin family member 14
Lung Adenocarcinoma (TCGA): 4.39e-6
Lung Adenocarcinoma (validation): 1.61e-4
CDC42EP2CDC42 effector protein 2
Lung Adenocarcinoma (TCGA): 4.41e-6
Liver Hepatocellular Carcinoma (TCGA): 4.00e-5
Liver Hepatocellular Carcinoma (validation): 4.07e-5
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 9.12e-4
PRR11Proline rich 11
Liver Hepatocellular Carcinoma (validation): 1.40e-8
Liver Hepatocellular Carcinoma (TCGA): 1.01e-6
Kidney Renal Papillary Cell Carcinoma (TCGA): 2.24e-6
Lung Adenocarcinoma (TCGA): 4.72e-6
Kidney Chromophobe (TCGA): 5.78e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.61e-4
Lung Adenocarcinoma (validation): 6.87e-4
MARVELD1MARVEL domain containing 1
Lung Adenocarcinoma (TCGA): 5.30e-6
Colon Adenocarcinoma (TCGA): 1.50e-4
Ovary Serous Cystadenocarcinoma (validation): 1.70e-4
Glioblastoma Multiforme (validation): 6.49e-4
Ovary Serous Cystadenocarcinoma (TCGA): 8.74e-4
ANP32BAcidic nuclear phosphoprotein 32 family member B
Liver Hepatocellular Carcinoma (TCGA): 2.94e-7
Liver Hepatocellular Carcinoma (validation): 5.44e-6
Lung Adenocarcinoma (TCGA): 5.48e-6
Uterine Corpus Endometrial Carcinoma (TCGA): 8.32e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 2.06e-4
CLSPNClaspin
Lung Adenocarcinoma (TCGA): 5.94e-6
Lung Adenocarcinoma (validation): 9.04e-5
Stomach Adenocarcinoma (TCGA): 4.07e-4
METTL5Methyltransferase 5, N6-adenosine
Liver Hepatocellular Carcinoma (validation): 1.30e-6
Liver Hepatocellular Carcinoma (TCGA): 1.72e-6
Lung Adenocarcinoma (TCGA): 6.52e-6
Pancreatic Adenocarcinoma (TCGA): 1.33e-5
Breast Invasive Carcinoma (TCGA): 2.04e-4
STRAPSerine/threonine kinase receptor associated protein
Liver Hepatocellular Carcinoma (validation): 3.24e-8
Kidney Renal Clear Cell Carcinoma (TCGA): 2.31e-7
Lung Adenocarcinoma (TCGA): 6.77e-6
Liver Hepatocellular Carcinoma (TCGA): 4.46e-5
Ovary Serous Cystadenocarcinoma (TCGA): 1.84e-4
Bladder Urothelial Carcinoma (TCGA): 5.95e-4
FAM72DFamily with sequence similarity 72 member D
Lung Adenocarcinoma (TCGA): 6.88e-6
Lung Adenocarcinoma (validation): 2.04e-5
PDSS1Decaprenyl diphosphate synthase subunit 1
Liver Hepatocellular Carcinoma (validation): 5.57e-6
Lung Adenocarcinoma (TCGA): 7.63e-6
Glioblastoma Multiforme (validation): 1.28e-5
Liver Hepatocellular Carcinoma (TCGA): 6.80e-5
Kidney Renal Clear Cell Carcinoma (TCGA): 5.19e-4
KIF20AKinesin family member 20A
Kidney Renal Papillary Cell Carcinoma (TCGA): 1.32e-12
Kidney Renal Clear Cell Carcinoma (TCGA): 1.12e-11
Liver Hepatocellular Carcinoma (TCGA): 4.68e-9
Liver Hepatocellular Carcinoma (validation): 5.05e-8
Kidney Renal Clear Cell Carcinoma (validation): 1.58e-6
Pancreatic Adenocarcinoma (TCGA): 7.84e-6
Lung Adenocarcinoma (TCGA): 7.90e-6
Lung Adenocarcinoma (validation): 1.36e-5
Kidney Chromophobe (TCGA): 4.65e-5
Page of 44 | next ยป